Anxiety Disorders
Disease State Hub
Featured
05/15/2023
Following two 12-week studies, the FDA has approved the first ever medication for treating agitation in patients with dementia due to Alzheimer disease.
05/15/2023
04/10/2023
In this video, Serena Orr, MD, MSc, speaks about her team’s study, “Anxiety and Depressive Symptoms and Disorders in Children and Adolescents With Migraine.” Dr Orr talks about how the results of the study...
04/10/2023
Interactive Features
07/07/2022
Concomitant anxiety is common among patients with restless legs syndrome (RLS). Based on the AAN’s guideline on RLS treatment in adults, which medication is recommended for patients with RLS and concomitant...
07/07/2022
Clinical Insights
04/10/2023
In this video, Serena Orr, MD, MSc, speaks about her team’s study, “Anxiety and Depressive Symptoms and Disorders in Children and Adolescents With Migraine.” Dr Orr talks about how the results of the study...
04/10/2023
02/10/2023
In this Q&A, Sat Bir S. Khalsa, PhD, answered our questions about his team’s study that evaluated the efficacy of yoga vs cognitive behavioral therapy vs stress education for the treatment of generalized...
02/10/2023
